Core Viewpoint - On July 7, a total of 30 listed companies had their restricted shares unlocked, with a total market value of approximately 15.657 billion yuan [1] Summary by Category Restricted Share Unlocking - Xiamen Xinda (000701) had 4.5378 million shares unlocked under equity incentive restrictions - Qianjiang Motorcycle (000913) had 117,500 shares unlocked under equity incentive restrictions - Shenhuo Co. (000933) had 5.1992 million shares unlocked under equity incentive restrictions - Xiamen Xiangyu (600057) had 28.3365 million shares unlocked under equity incentive restrictions - Inner Mongolia First Machinery (600967) had 20,630 shares unlocked under equity incentive restrictions - Bowei Alloys (601137) had 720,000 shares unlocked under equity incentive restrictions - Kebo Da (603786) had 1.5424 million shares unlocked under equity incentive restrictions - Jianke Co. (301115) had 90,000 shares unlocked under equity incentive restrictions - Jinhai Biological (002688) had 6.411 million shares unlocked under equity incentive restrictions - Tiantian Technology (300587) had 2.1044 million shares unlocked under equity incentive restrictions - Shengbang Co. (301233) had 994,200 shares unlocked under pre-issue restrictions - Zhonglan Environmental (300854) had 797,500 shares unlocked under equity incentive restrictions - Bidetech (605298) had 1.23 million shares unlocked under equity incentive restrictions - Tian'ao Electronics (002935) had 1.8468 million shares unlocked under equity incentive restrictions - Zhongyi Technology (301208) had 510,000 shares unlocked under pre-issue restrictions - Dielian Technology (300679) had 28,710 shares unlocked under equity incentive restrictions - Xishanghai (605151) had 544,000 shares unlocked under equity incentive restrictions - Dingsheng New Materials (603876) had 324,000 shares unlocked under equity incentive restrictions - Keli Sensor (603662) had 118,800 shares unlocked under equity incentive restrictions - Keri Technology (002957) had 451,100 shares unlocked under equity incentive restrictions - Puri Eye Hospital (301239) had 78.8296 million shares unlocked under pre-issue restrictions - Wuzhou Medical (301234) had 49.572 million shares unlocked under pre-issue restrictions - Sanwei Tiandi (301159) had 30.4475 million shares with extended lock-up period unlocked - Hush Silicon Industry (688126) had 11.3603 million shares unlocked - Junshi Biosciences (688180) had 1.8452 million shares unlocked - Olin Bio (688319) had 224,700 shares unlocked - Guoxin Technology (688262) had 71.6493 million shares unlocked - Yahui Pharmaceutical (688176) had 129 million shares unlocked - Lingyun Optical (688400) had 224 million shares unlocked - Aobi Zhongguang (688322) had 34.0322 million shares unlocked [1]

Group 1 - The establishment of the "American Party" by Elon Musk is seen as a response to the current political landscape, with Musk claiming the country is in a state of a single-party system due to waste and corruption [2][33] - Musk's political ambitions may face significant challenges, as he is unlikely to secure any electoral votes in upcoming elections [33] Group 2 - The Chinese government has implemented measures targeting medical devices imported from the EU, effective from July 6, 2025, which will affect procurement processes for medical equipment [3][5] - The measures specifically exclude products produced by European-funded enterprises in China, indicating a focus on imported goods rather than domestic production [5] Group 3 - The Chinese government has launched a plan to enhance the home service industry, with 14 specific tasks aimed at improving quality and expanding capacity, contributing to rural revitalization [6] - The plan includes measures to ensure employment security for rural laborers in the home service sector and improve their access to public services [6] Group 4 - The State-owned Assets Supervision and Administration Commission (SASAC) has issued guidelines to promote brand building among central enterprises, aiming for significant improvements in brand value by 2030 and 2035 [8] - The initiative emphasizes the importance of brand influence and competitiveness in the global market [8] Group 5 - The Hong Kong stock market has seen a significant increase in IPO fundraising, with over HKD 107 billion raised in the first half of the year, marking a 22% increase compared to the previous year [14] - The surge in IPO activity is primarily driven by investor interest in technology stocks [14] Group 6 - The domestic weight loss drug market is experiencing a shift with the introduction of the domestic GLP-1 weight loss drug, which may lead to increased competition for global giants like Novo Nordisk and Eli Lilly [34] - The pricing of weight loss drugs in China is currently high, but the entry of more products could lead to price reductions and potential inclusion in health insurance [34]

Economic Indicators - The CPI and PPI data for June will be released on July 9, with Huatai Securities predicting a year-on-year CPI increase to 0.1% and a narrowing PPI decline to 3% due to rising international oil prices [2] - Zhejiang Securities forecasts a weaker CPI performance for June, with a year-on-year decrease of 0.2% and a month-on-month decrease of 0.2%, while PPI is expected to remain stable with a year-on-year decline of 3.3% and a month-on-month decrease of 0.2% [2] Financial Data - In addition to CPI and PPI, financial data for June, including new loans, M2, and social financing, is expected to be released next week [3] - Zhejiang Securities anticipates that the monetary policy will maintain a loose tone throughout the year, with expectations of one 50 basis point reserve requirement ratio cut and a 20 basis point interest rate cut in 2025 [3] New Financial Products - The first batch of 10 science and technology innovation bond ETFs will be issued starting July 7, with various fund companies participating [4] - The ETFs will track different indices, including the CSI AAA Science and Technology Innovation Bond Index and the SSE AAA Science and Technology Innovation Bond Index [4] Stock Unlocking Events - A total of 52 companies will have their restricted shares unlocked from July 7 to July 11, with a peak on July 7 when 24 companies will unlock shares [5] - The companies with the highest unlocking market value include Lingyun Guang (5.953 billion), Haohua Technology (4.263 billion), and Weike Technology (3.636 billion) [5] New Stock Issuance - A new stock, Huadian New Energy, will be issued with approximately 4.969 billion shares at a price of 3.18 yuan per share, with online subscription starting on July 7 [9]

Core Insights - A total of 50 companies will have their restricted shares unlocked next week, from July 7 to July 11, with a total of 1.364 billion shares being released, amounting to a market value of 37.619 billion yuan based on the closing price on July 4 [1] Summary by Category Unlocking Schedule - The peak unlocking day is July 7, with 24 companies releasing shares worth a total of 19.109 billion yuan, accounting for 50.79% of the total unlocking value for the week [1] Companies with Highest Unlocking Value - The companies with the highest unlocking market value are: - Lingyun Guang: 5.952 billion yuan - Haohua Technology: 4.263 billion yuan - Weike Technology: 3.636 billion yuan [1] Companies with Highest Unlocking Volume - The companies with the highest number of shares being unlocked are: - Lingyun Guang: 224 million shares - Haohua Technology: 161 million shares - Anda Technology: 140 million shares [1]

Group 1 - The company has made a commitment not to reduce or transfer shares held by its actual controllers for 12 months starting from July 7, 2025, following the unlocking of 224 million shares [1] - The company has successfully acquired JAI and is actively integrating both companies' operations, focusing on enhancing their core competitiveness and market influence in the international market [1] - The consumer electronics industry is experiencing a mild recovery, driven by AI technology, new product iterations, and supportive government policies, which collectively contribute to a positive outlook for the sector [1] Group 2 - The company is focusing on domestic substitution in configurable vision systems and upgrading industrial intelligent production lines as key growth drivers in the consumer electronics sector [1] - The company is committed to sustainable development by expanding product offerings and conducting market research to meet future product demands [1] - The company is enhancing algorithm versatility and usability to meet new market demands, achieving high accuracy in defect detection models [1] Group 3 - The company is investing in research and development for next-generation products in key areas such as consumer electronics, new energy, and semiconductors, collaborating with major clients like Foxconn [1] - The integration of visual technology, AI algorithms, and big data analysis into manufacturing processes is expected to improve production efficiency and product quality [1] - The company has developed a comprehensive solution for humanoid robots, including high-precision quality control systems for mass production [2]

证券代码：688400 证券简称：凌云光 公告编号：2025-057 凌云光技术股份有限公司 关于以集中竞价交易方式 第四次回购公司股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 因实施 2024 年年度权益分派，公司本次以集中竞价交易方式回购股份价格上 限由不超过人民币 35.00 元/股（含）调整为不超过人民币 34.98 元/股（含）。 具体内容详见 2025 年 6 月 16 日于上海证券交易所网站（www.sse.com.cn）披露 的《关于 2024 年年度权益分派实施后调整回购价格上限的公告》。 二、回购股份的进展情况 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》的相关规定，现将公司第四次回购进展情况公告如下： 截至 2025 年 06 月 30 日，公司通过上海证券交易所交易系统以集中竞价交易 方式首次回购公司股份 17,515 股，占公司总股本 46,097.67 万股的比例为 0.0038%， 回购成交的最高价为 28.63 元/股 ...

Core Insights - The core technology for humanoid robots is motion control, which is essential for dynamic gait, precise operations, and environmental adaptability [1] - The humanoid robot industry faces both opportunities and challenges, with potential applications in various sectors such as industrial automation, medical rehabilitation, and education [1] - Precise complex motion control technology is fundamental for the widespread application of humanoid robots [2] Industry Overview - Humanoid robots are characterized by human-like form and functions, and their development is driven by advancements in robotics control and AI technology [1] - The industry is experiencing rapid evolution due to continuous influx of capital and talent, although large-scale commercialization still faces technical, economic, and social challenges [1] Motion Control Techniques - Motion control for humanoid robots can be categorized into model-based control and data-driven control, each with unique advantages [3] - Model-based control relies on accurate modeling and manual parameter adjustments, while data-driven control allows robots to learn motion strategies from experience [3] - A hybrid control approach combines both methods to enhance adaptability and robustness, improving the operational capabilities of humanoid robots [3] Key Players and Beneficiaries - Leading companies like Tesla with Optimus, Yushun with G1, and Boston Dynamics with Atlas demonstrate strong motion control capabilities [4] - The development of motion control software algorithms is typically conducted in-house by robot manufacturers, while hardware components may be sourced from third-party suppliers [4] - Training-related hardware such as motion capture devices and simulation software tools are often provided by third-party vendors or open-source platforms [4]

Core Viewpoint - The report outlines the verification opinion of China International Capital Corporation regarding the listing and circulation of restricted shares of Lingyun Optical Technology Co., Ltd. after its initial public offering, emphasizing compliance with relevant regulations and the commitment of shareholders not to reduce their holdings for a specified period [1][10]. Group 1: Restricted Shares Listing - The restricted shares being listed for circulation total 223,777,585 shares, representing 48.5442% of the company's total share capital [9]. - The listing date for these restricted shares is set for July 7, 2025, as July 6, 2025, is a non-trading day [9]. - The total number of shares issued during the initial public offering was 10,350,000, with a total share capital of 463,500,000 shares post-IPO [1]. Group 2: Changes in Share Capital - Following the repurchase and cancellation of 2,523,267 shares, the company's total share capital decreased from 463,500,000 shares to 460,976,733 shares [2]. - No other events have occurred that would affect the number of shares since the formation of the restricted shares [2]. Group 3: Shareholder Commitments - Shareholders have committed not to transfer or reduce their holdings of restricted shares for 36 months from the date of the IPO [3][4]. - If the share price falls below the IPO price, the lock-up period will automatically extend by at least 6 months [3]. - The controlling shareholders have voluntarily committed not to transfer or reduce their holdings for 12 months following the lifting of the lock-up period on July 7, 2025 [9]. Group 4: Compliance and Verification - The verification opinion confirms that the company has adhered to the relevant laws and regulations regarding the listing of restricted shares [10]. - The report states that the information disclosed by Lingyun Optical regarding the restricted shares is true, accurate, and complete [10].

Core Viewpoint - The announcement details the upcoming listing and circulation of 223,777,585 restricted shares of Lingyun Technology Co., Ltd., which will be available for trading starting July 7, 2025, following a voluntary commitment by shareholders not to reduce their holdings for 12 months [1][11]. Summary by Sections 1. Type of Restricted Shares - The restricted shares are part of the company's initial public offering (IPO) and were approved by the China Securities Regulatory Commission. The total number of shares issued in the IPO is 463,500,000, with 380,193,793 shares subject to restrictions, accounting for 82.03% of the total [2]. 2. Changes in Share Capital - Following the cancellation of 2,523,267 shares from a buyback plan, the company's total share capital decreased from 463,500,000 to 460,976,733 shares. No other changes in share capital have occurred since the formation of the restricted shares [3]. 3. Commitments Regarding Restricted Shares - Shareholders have committed not to transfer or reduce their holdings of restricted shares for 36 months from the IPO date. This commitment includes provisions for extending the lock-up period if certain conditions are met [6][10]. 4. Listing and Circulation Details - The total number of restricted shares to be listed is 223,777,585, which represents 48.5442% of the company's total share capital. The listing date is set for July 7, 2025 [11][12]. 5. Shareholder Commitment Not to Reduce Holdings - Major shareholders, including the controlling shareholder and management, have voluntarily committed not to transfer or reduce their holdings for 12 months starting from the listing date. This commitment aims to promote the company's stable development and protect investor interests [13].

的核查意见 中国国际金融股份有限公司（以下简称"中金公司"或"保荐机构"）作为凌云 光技术股份有限公司（以下简称"凌云光"或"公司"）首次公开发行股票并在科创 板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《上海证券交易所 科创板股票上市规则》《科创板上市公司持续监管办法（试行）》《上海证券交易 所科创板上市公司自律监管指引第1号——规范运作》等相关法律、法规和规范 性文件的规定，对凌云光首次公开发行部分限售股上市流通暨承诺不减持事项进 行了核查，具体核查情况如下： 中国国际金融股份有限公司 关于凌云光技术股份有限公司 首次公开发行部分限售股上市流通暨承诺不减持事项 一、本次上市流通的限售股类型 根据中国证券监督管理委员会《关于同意凌云光技术股份有限公司首次公开 发行股票注册的批复》（证监许可〔2022〕719号），同意公司首次公开发行股票 的注册申请。并经上海证券交易所同意，公司首次向社会公众公开发行A股股票 90,000,000股（行使超额配售选择权之前），并于2022年7月6日在上海证券交易所 科创板上市。公司首次公开发行A股股票超额配售选择权已于2022年8月4日全额 行使，对应新增发行股数1 ...